Search
Powered By HealthLine
Special Offers
Health Tools
 Chemotherapy: Eating Adivce
 Chemotherapy Myths
 Chemotherapy Guide
 Stages of Chemotherapy
 Post-Chemo Accessories
Featured Conditions
 Diet & Exercise
 Breast Cancer
 Skin Cancer
 Prostate
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

'Phase 0' Trials Aim to Speed Cancer Drug Development


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Basal Cell Carcinoma
Bladder Cancer
Bone Cancer
More...

Related Healthscout Videos
 border=
Tracking Breast Cancer with Less Pain
No More Biopsies?
Dealing with Dying
5 Breast Cancer Myths
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
More...

Related Drug Information
 border=
Epogen
Iressa
Procrit
Topamax
More...

Related News Articles
 border=
Health Tip: If You Notice Blood in the Stools
Pregnancy May Protect Breast Cancer Survivors
Protein in Breast Tumors May Predict Chemo Response
Preventive Mastectomy May Not Lower Risks
More...


Page:  << Prev | 1 | 2 | 3

So why participate?

"Altruism is an enormously powerful motivator," explained Hill, adding that he believes it will be the force that drives future participation in phase 0 trials. However, he said he sees nothing ethically objectionable about compensating people for reasonable costs they might incur as participants, such as money spent for travel, food and overnight stays.

The National Cancer Institute does not offer cancer patients financial incentives to participate in trials, Doroshow said.

Text Continues Below



Study participants also need to be aware that phase 0 trials, like any trial, might involve invasive procedures, such as blood work and biopsies. Before enrolling in a study, people should ask how it might negatively impact them and how it would positively impact others, LoRusso said.

"Some people would say 'no' because they don't want to be a guinea pig, but there are people out there who want to advance the science for future patients if they can," she said.

More information

The U.S. National Cancer Institute has more on phase 0 trials.

Page:  << Prev | 1 | 2 | 3

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 4/17/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: James H. Doroshow, M.D., director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Md.; Patricia M. LoRusso, D.O., director, phase I clinical-pharmacology team, Barbara Ann Karmanos Cancer Institute, and professor, internal medicine, Wayne State University, Detroit; T. Patrick Hill, Ph.D., senior policy fellow, Edward J. Bloustein School of Planning and Public Policy, Rutgers, clinical research ethics consultant, Cancer Institute of New Jersey, New Brunswick, N.J.; Feb 1, 2007, Clinical Cancer Research; April 13, 2009, Journal of Clinical Oncology


About The HealthScout Network Contact Us
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy